Kisspeptin-10 Spray10mg
Kisspeptin-10 Spray Canada — Nasal Spray
KISS1 Receptor Research Peptide — Nasal Spray
Kisspeptin-10 is a synthetic decapeptide derived from the larger KISS1 peptide sequence. It is developed for controlled laboratory research involving KISS1 receptor (GPR54) signaling systems.
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
Kisspeptin-10 is a synthetic decapeptide derived from the larger KISS1 peptide sequence. It is developed for controlled laboratory research involving KISS1 receptor (GPR54) signaling systems.
In scientific literature, kisspeptin-10 is studied in experimental models examining hypothalamic-pituitary signaling pathways, reproductive axis regulation frameworks, and receptor-mediated endocrine signaling under in vitro and preclinical research conditions.
Third-party tested for purity, ID, quantity.
Kisspeptin-10 represents the biologically active C-terminal fragment of the KISS1 peptide and has been evaluated in research focused on KISS1 receptor interaction and neuroendocrine signaling systems. Experimental studies examine receptor binding dynamics and downstream signaling mechanisms within controlled laboratory environments.
Research publications have explored its interaction with hypothalamic signaling pathways and reproductive regulatory frameworks under preclinical and clinical research conditions.
The KISS1 gene was originally identified in oncology research before its role in neuroendocrine signaling was characterized. Subsequent investigations demonstrated the interaction of kisspeptins with the GPR54 (KISS1R) receptor, leading to expanded research into reproductive and hypothalamic signaling pathways.
Kisspeptin-10 became a commonly studied fragment due to its receptor activity profile in controlled experimental systems.
Laboratory investigations into kisspeptin-10 have focused on KISS1 receptor activation models and neuroendocrine signaling pathways. Research frameworks evaluate receptor-mediated interaction, hypothalamic signaling systems, and endocrine regulatory mechanisms under controlled in vitro and preclinical conditions.
2 of the 4 areas below are addressed directly by a paper cited on this page.
No paper cited on this page reports on kiss1, receptor or activation. This heading marks where Kisspeptin-10 Spray is discussed in the category rather than a question the cited literature answers, and it is worth knowing which of these areas has work behind it and which does not.
Addressed on this page by Thompson 2004. The work appeared in J Neuroendocrinol. Each is linked to its source record in the references below, so what was measured — and in what system — can be read rather than taken on trust.
Addressed on this page by Jayasena 2011, Thompson 2004. The work appeared in J Clin Endocrinol Metab and J Neuroendocrinol. Each is linked to its source record in the references below, so what was measured — and in what system — can be read rather than taken on trust.
No paper cited on this page reports on neuroendocrine. This heading marks where Kisspeptin-10 Spray is discussed in the category rather than a question the cited literature answers, and it is worth knowing which of these areas has work behind it and which does not.
The references section of this page cites 3 primary papers published between 2004 and 2011 — a thin record. Every citation is linked to its PubMed or DOI record so it can be read rather than taken on trust, and the summaries above describe what those papers report rather than what the compound is claimed to do.
Research compounds attract claims that outrun their evidence. Below are the ones most often encountered for Kisspeptin-10 Spray, set against what the papers cited on this page actually report. Where the record is thin or contested, that is stated rather than smoothed over.
Kisspeptin-10 Spray is also referred to as kiss1, kisspeptin.
Kisspeptin-10 Spray is commonly described online in connection with raised testosterone and improved fertility. In the research literature the same compound is filed under KISS1 receptor activation models, hypothalamic-pituitary signaling studies and reproductive axis research frameworks.
The 3 papers cited on this page, published between 2004 and 2011 describe laboratory and animal work. None reports a controlled trial in humans. Findings in cell culture or in a rodent model describe what happened in that system; they do not establish that the same occurs in humans, and this compound is not approved for human use.
Nothing above is a statement of what this material does. It is a summary of what has been published and what has not. Eppix Labs supplies research materials only and provides no dosing, administration or protocol guidance.
Verification for Kisspeptin-10 Spray is per lot, not per product. The current 10mg lot KSPN-CA-26G-10 returned 99.824% purity, 13.21 mg measured, 132.1% of the labelled 10 mg, assayed by Janoshik. Those figures are the laboratory's, published in full rather than reduced to a badge.
The lot code printed on the vial matches the code on the certificate for Kisspeptin-10 Spray. Matching the two is what confirms the unit in hand came from the batch that was tested — a certificate not tied to a lot code proves nothing about any particular unit.
Researchers who buy Kisspeptin-10 Spray in Canada through Eppix Labs receive the lot described by the certificate above: the code printed on the vial label is the code on the certificate, and both are searchable on the batch verification page.
Kisspeptin-10 Spray ships as a prepared solution rather than as lyophilized powder, so it is already past the point at which a powder would be reconstituted. That shortens handling but tightens storage: a compound in solution is less stable than the same compound dry, and refrigeration from arrival onward is the relevant control.
The stability window for a solution is shorter than the shelf life of a sealed lyophilized vial of the same compound. Records for laboratory work in this format should note the date the unit was opened, not only the date it was received.
Vials may appear empty on arrival. Lyophilized material collects at the base of the vial and is often not visible until the vial is inspected under direct light.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each vial contains 12mg of lyophilized kisspeptin-10. Independent third-party testing verifies purity, identity, and net content per batch.
The vial contains only the lyophilized peptide. Any laboratory materials required for experimental procedures must be sourced separately.
Duration depends entirely on research protocol, storage conditions, and laboratory application.
The effects of kisspeptin-10 on reproductive hormone release show sexual dimorphism in humans. J Clin Endocrinol Metab 96(12):E1963–E1972.
PubMedCentral and peripheral administration of kisspeptin-10 stimulates the hypothalamic-pituitary-gonadal axis. J Neuroendocrinol 16(10):850–858.
PubMedKisspeptin-10 inhibits bone-directed migration of GPR54-positive breast cancer cells.
PubMedRelated
Eppix Flash Sale −30%Peptides
Triple GIP / GLP-1 / Glucagon Agonist · 10, 20, 40 & 120 mg Retatrutide is a synthetic peptide developed for controlled laboratory research involving multi-receptor signaling systems. It is structurally designed to interact with GLP-1, GIP, and glucagon receptor pathways within experimental environments.
RETA-CA-26F-1099.637%
11.76 mg / 10 mg
$41.96$59.95CAD
Flash sale ends in
Eppix Flash Sale −30%Peptides
Dual GIP / GLP-1 Agonist · 10, 30 & 65 mg Tirzepatide is a synthetic peptide developed for controlled laboratory research involving dual incretin receptor signaling systems. It is structurally designed to interact with GLP-1 and GIP receptor pathways within experimental environments.
TIRZ-CA-26G-1099.634%
11.42 mg / 10 mg
$24.46$34.95CAD
Flash sale ends in
Eppix Flash Sale −30%Peptides
GLP-1 Receptor Agonist · 10 mg Semaglutide is a synthetic analogue of glucagon-like peptide-1 (GLP-1), a naturally occurring incretin hormone involved in glucose-dependent signaling. It is developed for controlled laboratory investigation within regulated experimental environments.
10 mgSEMA-CA-26F-1099.504%
11.27 mg / 10 mg
$38.46$54.95CAD
Flash sale ends in
Eppix Flash Sale −30%Peptides
Selective Amylin Agonist (LY3841136) · 10 mg This product is supplied as eloralintide (LY3841136), a long-acting, selective amylin receptor agonist studied in research on metabolic and body-weight regulation.
10 mgELOR-CA-26G-1099.810%
12.42 mg / 10 mg
$101.46$144.95CAD
Flash sale ends in
